Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer

Authors

Thomas Filleron (ORCID: https://orcid.org/0000-0003-0724-0659)
Vanessa Barbet (ORCID: https://orcid.org/0009-0001-2762-787X)
Louise Baschet
G. Chenuc
L. Bosquet (ORCID: https://orcid.org/0000-0001-5100-9425)
K. Thokagevistk
C. Esnault (ORCID: https://orcid.org/0000-0003-2896-6045)
Maurice Pérol
D. Pau (ORCID: https://orcid.org/0000-0001-7664-4521)
Matthias Monnereau

Institutions

Inserm (FR)
Université Paris-Saclay (FR)
La Ligue Contre le Cancer (FR)
Centre de recherche en Epidémiologie et Santé des Populations (FR)
Centre Léon Bérard (FR)
Roche (France) (FR)
Zimmer Biomet (France) (FR)
Institut Claudius Regaud (FR)
UniCancer Group (FR)
IQVIA (France) (FR)

Publication Details

Journal: BMC Medical Research Methodology
Published: 2025-03-01
DOI: https://doi.org/10.1186/s12874-025-02500-w
Citations: 1
Primary Topic: Lung Cancer Treatments and Mutations
Type: article
Field-Weighted Citation Impact: 1.52

Funders

Unicancer

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer

Thomas Filleron, Vanessa Barbet, Louise Baschet, G. Chenuc et al.

Mar 1, 2025

1 citations

BMC Medical Research Methodology

Lung Cancer Treatments and Mutations

1.52

article

Addressing challenges with Matching-Adjusted Indirect Comparisons to demonstrate the comparative effectiveness of entrectinib in metastatic ROS-1 positive Non-Small Cell Lung Cancer

Thomas Filleron, Vanessa Barbet, Louise Baschet, G. Chenuc, L. Bosquet, K. Thokagevistk, C. Esnault, Maurice Pérol, D. Pau, Matthias Monnereau

March 1, 2025article en

1 citations

Abstract

No abstract available for this paper.

BMC Medical Research MethodologyVol. 25(1)

Inserm (FR), Université Paris-Saclay (FR), La Ligue Contre le Cancer (FR), Centre de recherche en Epidémiologie et Santé des Populations (FR), Centre Léon Bérard (FR), Roche (France) (FR), Zimmer Biomet (France) (FR), Institut Claudius Regaud (FR), UniCancer Group (FR), IQVIA (France) (FR)

Unicancer

Openalex Percentile: Top 21%

Lung Cancer Treatments and Mutations

1.52

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.